Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
I-MAK’s Priti Radhakrishnan at Pop!Tech
I-MAK Director Chosen as NYU Law Alumni of the Month (November 2009)
I-MAK Director Selected to Asia 21 Summit in Malaysia
NYU Law Magazine profiles Priti Radhakrishnan
Scripnews.com covers Tahir Amin on expert patent review
India Rejects Gilead’s Tenofovir Patent Applications
The Treatment Timebomb
Brazilian Patent Office Issues Final Refusal for Tenofovir – But Gilead Files Divisional Application
UK All-Party Parliamentary Group on Aids to Urge Companies to Pool HIV Patents
Parliamentary Standing Committee Releases Report on Improving the Patent and Trade Mark Systems in India